ifosfamide and Pain
ifosfamide has been researched along with Pain in 9 studies
Pain: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gemcitabine was administered at a dose of 800 mg/m2 on days 1 and 8 and ifosfamide at a dose of 2 g/m2 on days 1 and 8 with adequate amount of Mesna." | 2.70 | Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group. ( Aravantinos, G; Bafaloukos, D; Dimopoulos, MA; Kalofonos, H; Kiamouris, C; Nicolaides, C; Pectasides, D; Visvikis, A; Xiros, N, 2001) |
| "Ifosfamide was administered by intravenous drip infusion at a daily dose of 2 g/m2 for 5 consecutive days, and mesna was intravenously administered at 20% of the ifosfamide dose, three times daily for 5 consecutive days." | 2.67 | Placebo-controlled double-blind comparative study on the preventive efficacy of mesna against ifosfamide-induced urinary disorders. ( Fukuoka, M; Furuse, K; Ikegami, H; Kawahara, M; Kodama, N; Masuda, N; Nakamura, S; Negoro, S; Nishio, H; Ohnoshi, T, 1991) |
| " Adverse effects on oral mucosa have been documented for several cytotoxic treatment regimens." | 1.30 | Oral mucosal side effects of cytotoxic chemotherapy of testicular cancer. A retrospective study. ( Fosså, SD; Herlofson, BB; Norman-Pedersen, K; Redfors, M, 1997) |
Research
Studies (9)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Osanai, T | 1 |
| Tsuchiya, T | 1 |
| Sugawara, M | 1 |
| Pereira, LM | 1 |
| Lima-Júnior, RC | 1 |
| Bem, AX | 1 |
| Teixeira, CG | 1 |
| Grassi, LS | 1 |
| Medeiros, RP | 1 |
| Marques-Neto, RD | 1 |
| Callado, RB | 1 |
| Aragão, KS | 1 |
| Wong, DV | 1 |
| Vale, ML | 1 |
| Brito, GA | 1 |
| Ribeiro, RA | 1 |
| Moro, C | 1 |
| Taino, R | 1 |
| Mandalà, M | 1 |
| Labianca, R | 1 |
| Mateu, J | 1 |
| Alzamora, M | 1 |
| Franco, M | 1 |
| Buisán, MJ | 1 |
| Weintraub, M | 1 |
| Adde, MA | 1 |
| Venzon, DJ | 1 |
| Shad, AT | 1 |
| Horak, ID | 1 |
| Neely, JE | 1 |
| Seibel, NL | 1 |
| Gootenberg, J | 1 |
| Arndt, C | 1 |
| Nieder, ML | 1 |
| Magrath, IT | 1 |
| Herlofson, BB | 1 |
| Norman-Pedersen, K | 1 |
| Redfors, M | 1 |
| Fosså, SD | 1 |
| Maubec, E | 1 |
| Oberlin, O | 1 |
| Belhadj, K | 1 |
| Roujeau, JC | 1 |
| Pectasides, D | 1 |
| Aravantinos, G | 1 |
| Kalofonos, H | 1 |
| Kiamouris, C | 1 |
| Bafaloukos, D | 1 |
| Xiros, N | 1 |
| Nicolaides, C | 1 |
| Visvikis, A | 1 |
| Dimopoulos, MA | 1 |
| Fukuoka, M | 1 |
| Negoro, S | 1 |
| Masuda, N | 1 |
| Furuse, K | 1 |
| Kawahara, M | 1 |
| Kodama, N | 1 |
| Ikegami, H | 1 |
| Nakamura, S | 1 |
| Nishio, H | 1 |
| Ohnoshi, T | 1 |
Trials
3 trials available for ifosfamide and Pain
| Article | Year |
|---|---|
Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclopho | 1996 |
Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; He | 2001 |
Placebo-controlled double-blind comparative study on the preventive efficacy of mesna against ifosfamide-induced urinary disorders.
Topics: Adult; Aged; Double-Blind Method; Female; Hematuria; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna | 1991 |
Other Studies
6 other studies available for ifosfamide and Pain
| Article | Year |
|---|---|
Rapid pain relief and marked sclerotic change of multiple bone metastases from a synovial sarcoma after treatment with intravenous pamidronate and chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neopla | 2009 |
Blockade of TRPA1 with HC-030031 attenuates visceral nociception by a mechanism independent of inflammatory resident cells, nitric oxide and the opioid system.
Topics: Abdomen; Acetanilides; Animals; Antineoplastic Agents, Alkylating; Cell Count; Colitis; Cystitis; Di | 2013 |
Buprenorphine-induced acute respiratory depression during ifosfamide-based chemotherapy.
Topics: Acute Disease; Adult; Analgesics, Opioid; Antineoplastic Agents, Alkylating; Buprenorphine; Humans; | 2006 |
Ifosfamide extravasation.
Topics: Chondroitinsulfatases; Extravasation of Diagnostic and Therapeutic Materials; Female; Humans; Ifosfa | 1994 |
Oral mucosal side effects of cytotoxic chemotherapy of testicular cancer. A retrospective study.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antine | 1997 |
[Subcutaneous inflammatory edema induced by MINE chemotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Capillary Leak Syndrome; Creatin | 2001 |